{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:22:48Z","timestamp":1695813768824},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.canlet.2005.07.017","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T21:19:34Z","timestamp":1126041574000},"page":"295-303","source":"Crossref","is-referenced-by-count":1,"title":["Germline variations of the topoisomerase II\u03b1 gene as risk factors for primary gastric B-cell lymphoma"],"prefix":"10.1016","volume":"238","author":[{"given":"Stephan","family":"Hellmig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Rosenstiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich Robert","family":"F\u00f6lsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2005.07.017_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/386329a0","article-title":"DNA topoisomerases. New break for archaeal enzyme","volume":"386","author":"Wang","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2005.07.017_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-1119(98)00468-5","article-title":"Structural organization of the human TOP2A and TOP2B genes","volume":"221","author":"Lang","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2005.07.017_bib3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/MCB.16.4.1500","article-title":"The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation","volume":"16","author":"Goswami","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2005.07.017_bib4","doi-asserted-by":"crossref","first-page":"34710","DOI":"10.1074\/jbc.M005179200","article-title":"Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469","volume":"275","author":"Escargueil","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2005.07.017_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/002215549704500210","article-title":"Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies","volume":"45","author":"Kellner","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.canlet.2005.07.017_bib6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1083\/jcb.103.6.2569","article-title":"Topoisomerase II: a specific marker for cell proliferation","volume":"103","author":"Heck","year":"1986","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.canlet.2005.07.017_bib7","first-page":"2073","article-title":"Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer","volume":"148","author":"Jarvinen","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2005.07.017_bib8","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0016-5085(97)80014-5","article-title":"What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?","volume":"113","author":"Thiede","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2005.07.017_bib9","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C","article-title":"Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue","volume":"53","author":"Isaacson","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2005.07.017_bib10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.leu.2403387","article-title":"Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome","volume":"18","author":"Schrader","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2005.07.017_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/01.MP.0000093626.15701.76","article-title":"Alterations in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1)","volume":"16","author":"Sougioultzis","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2005.07.017_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1097-0142(19910101)67:1+<271::AID-CNCR2820671311>3.0.CO;2-L","article-title":"The evolving role of etoposide in the management of lymphomas and Hodgkin's disease","volume":"67","author":"O'Reilly","year":"1991","journal-title":"Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.canlet.2005.07.017_bib13","first-page":"45","article-title":"The incidence of Helicobacter pylori infection","volume":"9","author":"Parsonnet","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2005.07.017_bib14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/annonc\/mdf177","article-title":"Incidence of gastric B-cell lymphomas: a population-based study in Germany","volume":"13","author":"Ullrich","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2005.07.017_bib15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/gut.52.12.1799","article-title":"Helicobacter pylori infection in Africa and Europe: enigma of host genetics","volume":"52","author":"Hellmig","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2005.07.017_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2005.07.017_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bies.950170906","article-title":"DNA topoisomerase II mutations and resistance to anti-tumor drugs","volume":"17","author":"Vassetzky","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/j.canlet.2005.07.017_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/gast.2000.19579","article-title":"Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma study group","volume":"119","author":"Fischbach","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2005.07.017_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0.CO;2-J","article-title":"Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease","volume":"42","author":"Lewin","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2005.07.017_bib20","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification [Clinical staging classification of non-Hodgkin's lymphomas (author's transl Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.07.017_bib21","first-page":"218","article-title":"Clinical staging classification of non-Hodgkin's lymphomas (author's transl)","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.canlet.2005.07.017_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","article-title":"Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis","volume":"102","author":"Radaszkiewicz","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2005.07.017_bib23","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(19)37054-1","article-title":"Cloning and characterization of the 5\u2019-flanking region of the human topoisomerase II alpha gene","volume":"267","author":"Hochhauser","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2005.07.017_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/bioinformatics\/17.7.654","article-title":"An integrated system for high throughput TaqMan based SNP genotyping","volume":"17","author":"Hampe","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2005.07.017_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/geno.1995.9003","article-title":"A comparison of linkage disequilibrium measures for fine-scale mapping","volume":"29","author":"Devlin","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.canlet.2005.07.017_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00451461","article-title":"Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families","volume":"80","author":"Krawczak","year":"1988","journal-title":"Hum. Genet."},{"key":"10.1016\/j.canlet.2005.07.017_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/00222615-32-2-105","article-title":"The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors","volume":"32","author":"Loffeld","year":"1990","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.canlet.2005.07.017_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-2000-13047","article-title":"Helicobacter pylori\u2014prevalence in the German population","volume":"62","author":"Seher","year":"2000","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.canlet.2005.07.017_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","article-title":"The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori","volume":"342","author":"Hussell","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2005.07.017_bib30","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie house, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2005.07.017_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2559.1990.tb01173.x","article-title":"Lymphomas of mucosa-associated lymphoid tissue (MALT)","volume":"16","author":"Isaacson","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2005.07.017_bib32","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1200\/JCO.2001.19.7.2041","article-title":"Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection","volume":"19","author":"Morgner","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2005.07.017_bib33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","article-title":"Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma","volume":"89","author":"Neubauer","year":"1997","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.canlet.2005.07.017_bib34","first-page":"198","article-title":"Indolent nonfollicular lymphomas: characteristics, treatment, and outcome","volume":"36","author":"Coiffier","year":"1999","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.canlet.2005.07.017_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(99)00522-2","article-title":"Low-grade MALT lymphoma of the stomach: a review of treatment options","volume":"46","author":"Schechter","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2005.07.017_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-4781(98)00134-1","article-title":"Clinical applications of anticancer drugs targeted to topoisomerase II","volume":"1400","author":"Hande","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2005.07.017_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/dkg033","article-title":"Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes","volume":"51","author":"Piddock","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.canlet.2005.07.017_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/AAC.46.2.350-359.2002","article-title":"Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae. A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance","volume":"46","author":"Goni-Urriza","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.canlet.2005.07.017_bib39","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/JCM.38.9.3231-3234.2000","article-title":"Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis","volume":"38","author":"Niemann","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.canlet.2005.07.017_bib40","first-page":"4729","article-title":"Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II","volume":"51","author":"Hinds","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.07.017_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1615\/CritRevEukarGeneExpr.v9.i3-4.120","article-title":"Chromosomal DNA loops may constitute basic units of the eukaryotic genome organization and evolution","volume":"9","author":"Razin","year":"1999","journal-title":"Crit. Rev. Eukaryot. Gene. Expr."},{"key":"10.1016\/j.canlet.2005.07.017_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00418242","article-title":"Chromosome recombination and defective genome segregation induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26","volume":"100","author":"Charron","year":"1991","journal-title":"Chromosoma"},{"key":"10.1016\/j.canlet.2005.07.017_bib43","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.leu.2400769","article-title":"Chemotherapy-related\u2014late occurring\u2014Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?","volume":"11","author":"Pedersen-Bjergaard","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2005.07.017_bib44","doi-asserted-by":"crossref","first-page":"10550","DOI":"10.1074\/jbc.273.17.10550","article-title":"The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock","volume":"273","author":"Furukawa","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2005.07.017_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0022-2836(92)90245-F","article-title":"Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II","volume":"223","author":"Lee","year":"1992","journal-title":"J. Mol. Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383505007007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383505007007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T01:28:00Z","timestamp":1626485280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383505007007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0304383505007007"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2005.07.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}